Demand for non-surgical injectables shows no sign of slowing.
The forecasts
One widely cited forecast from ResearchAndMarkets puts the global aesthetic injectables market at about $15.45bn in 2026, up from roughly $14bn in 2025, growing at around 11% a year to reach about $29bn by 2032. Other research firms put 2026 a little higher, at around $17–18bn, so treat any single number as an estimate.
North America is the biggest market, with roughly 40% of revenue, but growth is strong in Europe, Brazil and Asia too.
What’s driving it
Researchers point to demand for treatments with little downtime, newer hyaluronic acid fillers and toxins, and “maintenance” appointments becoming part of regular routines.
For UK clients: growth makes choosing a well-trained, insured practitioner more important than ever, especially while England’s licensing scheme is still on hold.
